stock
ALKS · Alkermes plc.
What Alkermes plc. reports to the SEC, read from its filings.
Open in the appPrice
The live ALKS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ALKS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 167,763,272 as of 2026-07-23 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 7.0%
- Net
- 4.0%
Returns
- ROE
- 3.7%
- ROA
- 1.5%
Health
- Current ratio
- 2.3x
- Debt/equity
- 0.8x
Deep value
- NCAV
- -$1.06B
- NCAV per share
- -$6.33
- Price/NCAV
- Locked
- NNWC
- -$1.92B
- NNWC per share
- -$11.47
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $496.01M | —Gross profit: unreported by this company. | $18.35M | $501,000 | 10-Q filed 2026-07-28 |
| 2026-03-31 | $392.91M | —Gross profit: unreported by this company. | -$48.28M | -$66.48M | 10-Q filed 2026-07-28 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $384.55M | —Gross profit: unreported by this company. | $58.10M | $49.38M | DEF 14A filed 2026-04-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $394.19M | —Gross profit: unreported by this company. | $89.08M | $82.76M | 10-Q filed 2025-10-28 |
| 2025-06-30 | $390.66M | —Gross profit: unreported by this company. | $92.98M | $87.10M | 10-Q filed 2026-07-28 |
| 2025-03-31 | $306.51M | —Gross profit: unreported by this company. | $13.79M | $22.46M | 10-Q filed 2026-07-28 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $429.99M | —Gross profit: unreported by this company. | $162.69M | $146.53M | DEF 14A filed 2026-04-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $378.14M | —Gross profit: unreported by this company. | $104.76M | $92.38M | 10-Q filed 2025-10-28 |
- Assets
- $4.39B
- Equity
- $1.81B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $1.48B | $253.96M | $241.70M | $480.33M |
| 2024-12-31 | $1.56B | $420.64M | $367.10M | $405.64M |
| 2023-12-31 | $1.66B | $414.12M | $355.80M | $353.31M |
| 2022-12-31 | $1.11B | -$6.09M | -$158.30M | -$17.21M |
| 2021-12-31 | $1.17B | $97.75M | -$48.20M | $73.69M |
| 2020-12-31 | $1.04B | -$112.43M | -$110.86M | $40.62M |
| 2019-12-31 | $1.17B | -$175.48M | -$196.62M | -$18.86M |
| 2018-12-31 | $1.09B | -$99.13M | -$139.31M | $29.85M |
| 2017-12-31 | $903.37M | -$147.90M | -$157.94M | -$32.11M |
| 2016-12-31 | $745.69M | -$208.66M | -$208.44M | -$107.46M |
Company filings
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventSep 218-KExecutive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureSep 168-KMaterial agreement
Material agreementAug 128-KExecutive or director change
Executive or director changeAug 38-K/AResults
ResultsJul 288-KAgreement ended
Agreement endedJul 88-K
5% owners ()
T. Rowe Price Associates, Inc.
Stake update
Vanguard Portfolio Management
Passive stake
Vanguard Capital Management
Passive stake
The Vanguard Group
Stake update
Baker Bros. Advisors LP
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale$83,455Oct 2, 6:22 PM ET
Gaffin David Joseph
EVP, CLO, Alkermes, Inc.
Sale$97,652Sep 3, 6:32 PM ET
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sale$422,874Sep 1, 7:08 PM ET
Nichols Christian Todd
SVP, Chief Commercial Officer
Sale$372,937Aug 17, 6:53 PM ET
snyderman nancy lynn MD
Director
Sale$2,239,076Aug 3, 7:16 PM ET
Politician trades, last 90 days
Gilbert Cisneros
House · CA31
Buy$15,001 to $50,000Fri Sep 4
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named ALKS, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about ALKS.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on ALKS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ALKS board